This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boukerche, H. Articles by Fisher, P. B. Search for Related Content PubMed PubMed Citation Articles by Boukerche, H. Articles by Fisher, P. B.

mda-9/Syntenin: A Positive Regulator of Melanoma Metastasis

Departments of ¹ Pathology, ² Urology, and ³ Neurosurgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York; ⁴ Departments of Pathology and Dermatology at Hôpital de l'Hôtel Dieu, Lyon, France; and ⁵ Department of Radiation Oncology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia

Requests for reprints: Paul B. Fisher, Department of Pathology, Columbia University Medical Center, College of Physicians and Surgeons, Room 1501, Black Building, 630 West 168th Street, New York, NY 10032. Phone: 212-305-3642; Fax: 212-305-8177; E-mail: pbf1{at}columbia.edu.

Metastasis is a significant event in cancer progression and continues to pose the greatest challenge for a cancer cure. Defining genes that control metastasis in vivo may provide new targets for intervening in this process with profound therapeutic implications. Melanoma differentiation associated gene-9 (mda-9) was initially identified by subtraction hybridization as a novel gene displaying biphasic expression during terminal differentiation in human melanoma cells. Mda-9, also known as syntenin, is a PDZ-domain protein overexpressed in many types of human cancers, where it is believed to function in tumor progression. However, a functional role of mda-9/syntenin in tumor growth and metastasis and the signaling pathways involved in mediating these biological activities remain to be defined. Evidence is now provided, using weakly and highly metastatic isogenic melanoma variants, that mda-9/syntenin regulates metastasis. Expression of mda-9/syntenin correlates with advanced stages of melanoma progression. Regulating mda-9/syntenin expression using a replication-incompetent adenovirus expressing either sense or antisense mda-9/syntenin modifies the transformed phenotype and alters metastatic ability in immortal human melanocytes and metastatic melanoma cells in vitro and in vivo in newborn rats. A direct relationship is observed between mda-9/syntenin expression and increased phosphorylation of focal adhesion kinase, c-Jun-NH₂-kinase, and p38. This study provides the first direct link between mda-9/syntenin expression and tumor cell dissemination in vivo and indicates that mda-9/syntenin expression activates specific signal transduction pathways, which may regulate melanoma tumor progression. Based on its ability to directly alter metastasis, mda-9/syntenin provides a promising new focus for melanoma cancer research with potential therapeutic applications for metastatic diseases.

This article has been cited by other articles:

				B. Sulka, H. Lortat-Jacob, R. Terreux, F. Letourneur, and P. Rousselle Tyrosine Dephosphorylation of the Syndecan-1 PDZ Binding Domain Regulates Syntenin-1 Recruitment J. Biol. Chem., April 17, 2009; 284(16): 10659 - 10671. [Abstract] [Full Text] [PDF]

				H. Boukerche, Z.-z. Su, C. Prevot, D. Sarkar, and P. B. Fisher mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src PNAS, October 14, 2008; 105(41): 15914 - 15919. [Abstract] [Full Text] [PDF]

				V. Brune, E. Tiacci, I. Pfeil, C. Doring, S. Eckerle, C. J.M. van Noesel, W. Klapper, B. Falini, A. von Heydebreck, D. Metzler, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis J. Exp. Med., September 29, 2008; 205(10): 2251 - 2268. [Abstract] [Full Text] [PDF]

				D. Sarkar, H. Boukerche, Z.-z. Su, and P. B. Fisher mda-9/Syntenin: More than Just a Simple Adapter Protein When It Comes to Cancer Metastasis Cancer Res., May 1, 2008; 68(9): 3087 - 3093. [Abstract] [Full Text] [PDF]

				J. M. Beekman and P. J. Coffer The ins and outs of syntenin, a multifunctional intracellular adaptor protein J. Cell Sci., May 1, 2008; 121(9): 1349 - 1355. [Abstract] [Full Text] [PDF]

				A. Luyten, E. Mortier, C. Van Campenhout, V. Taelman, G. Degeest, G. Wuytens, K. Lambaerts, G. David, E. J. Bellefroid, and P. Zimmermann The Postsynaptic Density 95/Disc-Large/Zona Occludens Protein Syntenin Directly Interacts with Frizzled 7 and Supports Noncanonical Wnt Signaling Mol. Biol. Cell, April 1, 2008; 19(4): 1594 - 1604. [Abstract] [Full Text] [PDF]

				H. Boukerche, Z.-z. Su, L. Emdad, D. Sarkar, and P. B. Fisher mda-9/Syntenin Regulates the Metastatic Phenotype in Human Melanoma Cells by Activating Nuclear Factor-{kappa}B Cancer Res., February 15, 2007; 67(4): 1812 - 1822. [Abstract] [Full Text] [PDF]

				N. Latysheva, G. Muratov, S. Rajesh, M. Padgett, N. A. Hotchin, M. Overduin, and F. Berditchevski Syntenin-1 Is a New Component of Tetraspanin-Enriched Microdomains: Mechanisms and Consequences of the Interaction of Syntenin-1 with CD63 Mol. Cell. Biol., October 15, 2006; 26(20): 7707 - 7718. [Abstract] [Full Text] [PDF]